JD LLB - Talaris Therapeutics CEO and President
| TALSDelisted Stock | USD 2.98 0.10 3.25% |
Insider
JD LLB is CEO and President of Talaris Therapeutics
| Age | 54 |
| Phone | 502 398 9250 |
| Web | https://talaristx.com |
Talaris Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.2281) % which means that it has lost $0.2281 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4164) %, meaning that it created substantial loss on money invested by shareholders. Talaris Therapeutics' management efficiency ratios could be used to measure how well Talaris Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Talaris Therapeutics currently holds 2.88 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Talaris Therapeutics has a current ratio of 28.34, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Talaris Therapeutics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| CPA CPA | NextCure | 61 | |
| Michele Anderson | Assembly Biosciences | N/A | |
| Veit Schmelmer | Vor Biopharma | N/A | |
| W Vernon | Nuvation Bio | 65 | |
| Dr IV | Assembly Biosciences | 52 | |
| Christopher Ogden | CytomX Therapeutics | 40 | |
| DSc FACP | Ovid Therapeutics | 65 | |
| David Hanley | Nuvation Bio | 54 | |
| Ian Critchley | Spero Therapeutics | N/A | |
| MBA BS | CytomX Therapeutics | 45 | |
| DPHIL MD | Vor Biopharma | 51 | |
| MBA MD | Spero Therapeutics | 43 | |
| MBA MD | Cullinan Oncology LLC | 51 | |
| Raul Collazo | Connect Biopharma Holdings | N/A | |
| Tharaknath Rao | Assembly Biosciences | N/A | |
| Jacquelyn JD | Cullinan Oncology LLC | 46 | |
| Steve Andre | Cullinan Oncology LLC | N/A | |
| FMEDSCI MD | Achilles Therapeutics PLC | 49 | |
| Francesco MD | Adicet Bio | 56 | |
| MBA MD | Vor Biopharma | 47 | |
| Robert Coutts | Achilles Therapeutics PLC | 40 | |
Management Performance
| Return On Equity | -0.42 | |||
| Return On Asset | -0.23 |
Talaris Therapeutics Leadership Team
Elected by the shareholders, the Talaris Therapeutics' board of directors comprises two types of representatives: Talaris Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Talaris. The board's role is to monitor Talaris Therapeutics' management team and ensure that shareholders' interests are well served. Talaris Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Talaris Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nancy MD, Chief Officer | ||
| Eric Gornstein, Head Planning | ||
| Suzanne Tollerud, VP Devel | ||
| Michael Zdanowski, Chief Officer | ||
| JD LLB, CEO and President | ||
| Suzanne MD, Member Founder | ||
| Mary Fenton, CFO Treasurer | ||
| Farah Natoli, Head Management | ||
| Colby Suire, Head RD | ||
| Andrew Farnsworth, Chief Officer |
Talaris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Talaris Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.42 | |||
| Return On Asset | -0.23 | |||
| Current Valuation | (28.92 M) | |||
| Shares Outstanding | 42.81 M | |||
| Shares Owned By Insiders | 11.90 % | |||
| Shares Owned By Institutions | 77.67 % | |||
| Number Of Shares Shorted | 340.1 K | |||
| Price To Book | 0.28 X | |||
| EBITDA | (74.31 M) | |||
| Net Income | (73.89 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Talaris Stock
If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |